Privia Health Group, Inc. (PRVA)
NASDAQ: PRVA · Real-Time Price · USD
20.07
-0.06 (-0.30%)
Dec 20, 2024, 4:00 PM EST - Market closed
Privia Health Group Analyst Ratings
Total Analysts
13
Consensus Rating
Buy
Price Target
$24.46
Upside
+21.87%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Macquarie | Macquarie | Buy Initiates $25 | Buy | Initiates | $25 | +24.56% | Dec 16, 2024 |
| JP Morgan | JP Morgan | Buy Maintains $27 → $28 | Buy | Maintains | $27 → $28 | +39.51% | Nov 29, 2024 |
| Barclays | Barclays | Hold Maintains $19 → $21 | Hold | Maintains | $19 → $21 | +4.63% | Nov 8, 2024 |
| Truist Securities | Truist Securities | Strong Buy Maintains $24 → $27 | Strong Buy | Maintains | $24 → $27 | +34.53% | Nov 8, 2024 |
| Keybanc | Keybanc | Buy Initiates $23 | Buy | Initiates | $23 | +14.60% | Oct 11, 2024 |
| Baird | Baird | Buy Maintains $23 → $24 | Buy | Maintains | $23 → $24 | +19.58% | Aug 26, 2024 |
| RBC Capital | RBC Capital | Buy Reiterates $28 | Buy | Reiterates | $28 | +39.51% | Aug 14, 2024 |
| Evercore ISI Group | Evercore ISI Group | Buy Maintains $23 → $20 | Buy | Maintains | $23 → $20 | -0.35% | Jul 9, 2024 |
| Baird | Baird | Buy Initiates $23 | Buy | Initiates | $23 | +14.60% | May 30, 2024 |
| Barclays | Barclays | Hold Maintains $22 → $19 | Hold | Maintains | $22 → $19 | -5.33% | May 20, 2024 |
| Truist Securities | Truist Securities | Strong Buy Maintains $28 → $24 | Strong Buy | Maintains | $28 → $24 | +19.58% | May 15, 2024 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $37 → $26 | Strong Buy | Maintains | $37 → $26 | +29.55% | May 10, 2024 |
| Stifel | Stifel | Strong Buy Maintains $28 → $24 | Strong Buy | Maintains | $28 → $24 | +19.58% | May 1, 2024 |
| Citigroup | Citigroup | Strong Buy Initiates $25 | Strong Buy | Initiates | $25 | +24.56% | Apr 22, 2024 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $41 → $37 | Strong Buy | Maintains | $41 → $37 | +84.35% | Mar 19, 2024 |
| JP Morgan | JP Morgan | Buy Maintains $38 → $30 | Buy | Maintains | $38 → $30 | +49.48% | Mar 6, 2024 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.